|
DMD treatment Avonex© Betaferon/Extavia© Rebif© Copaxone© |
0.312 0.187 0.375 0.125 |
0.479 0.403 0.500 0.342 |
0 0 0 0 0 |
1 1 1 1 |
|
Symptoms experienced Diminished strength Paresis Difficulty in walking Difficulty in balance Sensitivity problems Sight problems Double vision Difficulty in speech Bladder disturbances Others |
0.750 0.625 0.687 0.750 0.875 0.562 0.750 0.500 0.500 0.250 |
0.447 0.500 0.488 0.447 0.342 0.512 0.447 0.516 0.516 0.447 |
0 0 0 0 0 0 0 0 0 0 |
1 1 1 1 1 1 1 1 1 1 |
|
Type of symptoms: Pyramidal symptoms Sensitivity symptoms Cerebellar symptoms Brainstem symptoms Visual symptoms Sphincter disorders Others |
0.750 0.875 0.812 0.562 0.562 0.500 0.250 |
0.447 0.341 0.403 0.512 0.512 0.516 0.447 |
0 0 0 0 0 0 0 |
1 1 1 1 1 1 1 |
| Years of therapy | 8.062 | 3.376 | 3 | 15 |
| Disadvantages (1 = yes; 0 = no) |
0.625 | 0.500 | 0 | 1 |
| Side effects (1 = yes; 0 = no) |
0.937 | 0.250 | 0 | 1 |
| Other drugs to contrast side effects | 0.562 | 0.512 | 0 | 5 |